Valion Bio VBIO
NASDAQ VBIO
$2.59 +0.08 (+3.19%)
At close: Oct 2, 2026 · 4:00 PM EDT

Valion Bio (VBIO) Income from Discontinued Operations (2025 - 2026)

Updated

Valion Bio (VBIO) posted Income from Discontinued Operations of -$46,000 for Q2 2026, compared with -$256,000 a year earlier.

Analysis

Valion Bio (VBIO) Income from Discontinued Operations (2025 - 2026) Analysis & Trends

For FY2025, Valion Bio's Income from Discontinued Operations came in at -$885,000.

  • In prior years, Valion Bio's Income from Discontinued Operations was -$1.19 million in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Discontinued) (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 8.00 Mn
10 Valion Bio 350,167.99 -19.09 Mn - -46,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -46,000.00
Jun 30, 2025 -256,000.00
API Access

Valion Bio Income from Discontinued Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-from-discontinued-operations&ticker=VBIO&period=max&api_key=YOUR_API_KEY